Open labelled trial of salvaged therapy for the patients who show resistance to 3rd line of Hp eradication therapy

Open labelled trial of salvaged therapy for the patients who show resistance to 3rd line of Hp eradication therapy - salvaged therapy for the patients who show resistance to 3rd line of Hp eradication therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007154

Enrollment

Registered

2012-01-27

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patinets who show resistance to 3rd line therapy

Interventions

PPI+AMPC+LVFX PPI+AMPC

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patinets who show resistace to the 3rd line therapy

Exclusion criteria

Exclusion criteria: Allergy for the drugs

Design outcomes

Primary

Measure	Time frame
Efficacy of Hp eradication	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026